| Officer | Age | In this role | Source |
|---|---|---|---|
|
Moshe Arkin
Also a director
Executive Chairman of the Board of Directors and interim Chief Executive Officer
|
73 | Not stated | |
|
Eyal Ben-Or
Chief Financial Officer
|
42 |
Since 2024
2 years
|
|
|
Itzik Yosef
Chief Operating Officer
|
49 |
Since 2020
6 years
|
|
|
Michael Glezin
Chief Business Officer
|
44 |
Since 2025
1 year
|
|
|
Ofer Toledano
Vice President Research and Development
|
61 |
Since 2004
22 years
|
|
|
Ofra Levy-Hacham
Vice President Clinical, Regulatory Affairs and Quality
|
60 |
Since 2024
2 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. Sol-Gel Technologies Ltd. has not filed one with the SEC.
Loading...